Please disable your adblock and script blockers to view this page

Treating COVID-19 may increase antibiotic resistance


AMR
the University of Plymouth
the Royal Cornwall Hospitals Trust
the Journal of Antimicrobial Chemotherapy
the World Health Organization (WHO
The National Institute for Health and Care Excellence COVID-19
School of Biomedical Sciences
research.“Currently


Neil Powell
Thomas Hutchinson
Sean Comber
Mathew Upton
Mathew UptonFinally
Winston Morgan


COVID-19

No matching tags


works’


the United Kingdom
AMR.“Common
U.K.
Harrogate

No matching tags

Positivity     33.00%   
   Negativity   67.00%
The New York Times
SOURCE: http://www.medicalnewstoday.com/articles/treating-covid-19-may-increase-antibiotic-resistance
Write a review: Medical News Today
Summary

The concern about resistance has led the World Health Organization (WHO) to discourage the use of antibiotics for mild cases of COVID-19, though they still recommend their use for people with severe COVID-19 who have a risk of secondary bacterial infections and death.The present research revealed that the increased use of antibiotics during the pandemic may also be placing an added burden on wastewater treatment works.The team noted that this could lead to raised levels of antibiotics within the U.K.’s rivers and coastal waters, which may in turn result in a rise in AMR.This would be particularly serious in receiving waters of these works that serve large hospitals or emergency hospitals, where there are high concentrations of COVID-19 patients.To perform a comprehensive environmental safety assessment that addresses potential risks to fish populations and related food webs, the researchers estimated the antibiotic loads entering the wastewater treatment works.This involved analyzing patient numbers in emergency hospitals set up temporarily around the country and taking into account the associated treatment works’ capacity and available river water dilution for the emergency hospital and associated town.The researchers employed environmental impact data from previous research and modeling tools developed by the U.K. water industry. For illustrative purposes, they focused on a single U.K. emergency hospital: Harrogate, which has a capacity of 500 beds.The National Institute for Health and Care Excellence COVID-19 guidelines recommend that patients with the virus receive the antibiotics doxycycline, amoxicillin, or a combination of others if their doctors suspect that a bacterial infection is present.However, the guidelines also recommend not administering or stopping the antibiotics if no bacterial infection is found.With these points in mind, the researchers predicted the possible effects of different scenarios involving antibiotic use during the COVID-19 pandemic — having all hospital beds occupied and having 70% or 95% of the patients receiving either doxycycline or amoxicillin.It is important to note that amoxicillin is used to treat a wide range of bacterial infections, including pneumonia, throat infections, and skin and ear infections.Thomas Hutchinson, a professor of environment and health at the University of Plymouth and the senior author of the research, says, “The data for amoxicillin indicated that while there was little threat of direct impacts on fish populations and other wildlife, there is a potential environmental concern for selection of AMR if at 100% capacity.”“From our previous research, we know that significant quantities of commonly prescribed drugs do pass through treatment works and into our water courses,” adds Sean Comber, a professor of environmental chemistry at the university and the article’s lead author.“By developing a greater understanding of their effects, we can potentially inform future decisions on prescribing during pandemics, but also on the location of emergency hospitals and wider drug and waste management,” says Prof.

As said here by Dibash Kumar Das, Ph.D.